Livzon Pharmaceutical Group Inc.
SHZ: 000513.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Daping Liu
- Employees
- 9,067
- Headquarters
- Zhuhai, China
- IPO year
- 1993
- Market cap
- CN¥28.4B
- Website
- https://www.livzon.com.cn
Loading 000513…
Loading profile data…Frequently asked questions about 000513
What does Livzon Pharmaceutical Group Inc. (000513.SZ) do?
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for i...
Where does 000513.SZ trade?
Livzon Pharmaceutical Group Inc. (000513.SZ) trades on the Shenzhen Stock Exchange.
What sector is 000513.SZ in?
Livzon Pharmaceutical Group Inc. (000513.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Livzon Pharmaceutical Group Inc.?
Daping Liu is the chief executive officer of Livzon Pharmaceutical Group Inc. (000513.SZ).
Where is Livzon Pharmaceutical Group Inc. headquartered?
Livzon Pharmaceutical Group Inc. is headquartered in China.
Does 000513.SZ pay a dividend?
Yes — Livzon Pharmaceutical Group Inc. (000513.SZ) paid a trailing twelve-month dividend of CNY 1.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 000513.SZ go public?
Livzon Pharmaceutical Group Inc. (000513.SZ) completed its initial public offering in 1993.